Skip to NavigationSkip to content

News

A French biopharma firm has received an order from the FDA to halt its study of CAR T therapy UCART123 after a 78-year old patient died as a result...
Novo Nordisk has agreed to pay $58.7 million to resolve a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing...
A new study has found that PrEP) drugs such as Truvada, which pre-emptively protects against the HIV, is safe to be used by gay and bisexual...
Bial and Eisai have released real-world data which support the efficacy of Zebinix in the treatment of partial-onset epilepsy in adults, as part of...
NICE has revealed that the outcome of its consultation process for Ninlaro (ixazomib), Takeda’s treatment for relapsed or refractory multiple myeloma...
Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit subsidiary Merck...
17 years after its first approval andn subsequent withdrawal, Mylotarg has been given a second shot. It has been approved for use in adults with...
Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod), finding that the drug met its...
Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business on becoming ‘a leading science...
A study has revealed that commonly prescribed asthma drugs have the ability to reduce the risk of developing Parkinson’s disease by around 50%.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches